my 12-62c has been researched along with quinidine in 1 studies
Studies (my 12-62c) | Trials (my 12-62c) | Recent Studies (post-2010) (my 12-62c) | Studies (quinidine) | Trials (quinidine) | Recent Studies (post-2010) (quinidine) |
---|---|---|---|---|---|
41 | 0 | 31 | 6,608 | 387 | 594 |
Protein | Taxonomy | my 12-62c (IC50) | quinidine (IC50) |
---|---|---|---|
Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 6.4 | |
Cholinesterase | Homo sapiens (human) | 1.23 | |
ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 10 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.32 | |
Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 2.8 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.3532 | |
Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 7.3 | |
Cholinesterase | Equus caballus (horse) | 7.37 | |
Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 6.4 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.7882 | |
Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 6.4 | |
Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 6.4 | |
Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.9 | |
Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | 2.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boesche, M; Crowther, GJ; Dasari, KS; Drewes, G; El Bakkouri, M; Fox, AM; Ghidelli-Disse, S; He, P; Hillesland, HK; Hui, R; Jones, JC; Keyloun, KR; Krahn, MM; Lafuente-Monasterio, MJ; Leonard, SE; Leroy, D; Maly, DJ; Mo, JS; Ojo, KK; Reid, MC; Rivas, KL; Van Voorhis, WC | 1 |
1 other study(ies) available for my 12-62c and quinidine
Article | Year |
---|---|
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
Topics: Antimalarials; Calcium; Cell Line, Tumor; Hep G2 Cells; Humans; Malaria, Falciparum; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Plasmodium falciparum; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protozoan Proteins | 2016 |